Cosmos Holdings competitors

Cosmos Holdings's competitors include Daiichi Sankyo, RespireRx Pharmaceuticals, Kadmon and Adamas Pharmaceuticals
Add company...
Cosmos Holdings
Cosmos Holdings is a fully reporting Pharmaceutical Holding Company based in Chicago, Illinois, USA, that specializes, through its subsidiaries, in the wholesale of pharmaceutical products throughout Europe.
Daiichi Sankyo
Daiichi Sankyo develops and markets pharmaceuticals.
RespireRx Pharmaceuticals
RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.
Kadmon
Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Founding Date
Founding Date
N/A
Founding Date
N/A
Founding Date
1988
Founding Date
2010
Founding Date
2002
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Chicago, US HQ
Locations
Parsippany-Troy Hills, US HQ
Locations
Glen Rock, US HQ
Locations
New York, US HQ
Locations
Emeryville, US HQ
Employees
Employees
1
Employees
3,168
Employees
1
Employees
10010% decrease
Employees
8415% increase
Valuation ($)
Valuation ($)
75 m
Valuation ($)
14.7 b
Valuation ($)
2.3 m
Valuation ($)
304.9 m
Valuation ($)
680.2 m

Financial

Revenue (est.)
Revenue (est.)
$30m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$12.3m (FY, 2017)
Revenue (est.)
$572k (FY, 2016)
Cost of goods
Cost of goods
$28.1m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$1.3m (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
$2m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
$10.9m (FY, 2017)
Gross profit
N/A
Net income
Net income
($6.2m) (FY, 2017)
Net income
N/A
Net income
($4.3m) (FY, 2017)
Net income
($79.8m) (FY, 2017)
Net income
($60.1m) (FY, 2016)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 21.3m
Total funding raised
$ 82m
For sources of this data, please see the company profileDownload Excel

View company profiles

Daiichi Sankyo
HQ
Parsippany-Troy Hills, US
Employees
3,168

Daiichi Sankyo develops and markets pharmaceuticals.

View company
RespireRx Pharmaceuticals
HQ
Glen Rock, US
Employees
1

RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.

View company
Kadmon
HQ
New York, US
Employees
100↓ 10% decrease

Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.

View company
Adamas Pharmaceuticals
HQ
Emeryville, US
Employees
84↑ 15% increase

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

View company